Robert W Simms

UNVERIFIED PROFILE

Are you Robert W Simms?   Register this Author

Register author

Robert W Simms

Publications by authors named "Robert W Simms"

Are you Robert W Simms?   Register this Author

35Publications

-Reads

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

N Engl J Med 2018 01;378(1):35-47

From the Duke University Medical Center (K.M.S., O.C., E.W.S.C.) and RTI International (D.W.), Durham, and Rho Federal Systems Division, Chapel Hill (L.K.-E., A.P., B.E., S.C.) - all in North Carolina; National Institute of Allergy and Infectious Diseases, Bethesda, MD (E.A.G., B.W., L.M.G., J.S.G.); Colorado Blood Cancer Institute, Denver (P.A.M., R.A.N.); University of Texas McGovern Medical School (M.D.M.) and M.D. Anderson Cancer Center (C.H.) - both in Houston; Vanderbilt University, Nashville (L.J.C., K.P.); University of Michigan, Ann Arbor (D.K., J.R.S.); Case Western Reserve University and University Hospitals, Cleveland (R.J.F.); University of Alabama, Birmingham (S.M.); Boston University, Boston (R.W.S.); University of Virginia, Charlottesville (K.B.); University of Washington (M.H.W., D.E.F.) and the Fred Hutchinson Cancer Research Center (G.E.G., S.H.) - both in Seattle; University of California, Los Angeles, Los Angeles (J.G., S.K., D.E.F.); City of Hope National Medical Center, Duarte, CA (S.F.); Medical University of South Carolina, Charleston (R.M.S.); Mayo Clinic, Scottsdale, AZ (L.G.); University of Calgary, Calgary, AB, Canada (J.S., S.L.); Washington University, St. Louis (R.B.); Medical College of Wisconsin, Milwaukee (M.E.C., C.K.-T.); Ottawa Hospital Research Institute, Ottawa (C.B.); University of Pittsburgh, Pittsburgh (T.M., R.T.D.); and University of Toledo Medical Center, Toledo, OH (M.B.K.).

View Article
January 2018

Development and validation of a patient-reported outcome instrument for skin involvement in patients with systemic sclerosis.

Ann Rheum Dis 2017 Aug 17;76(8):1374-1380. Epub 2017 Feb 17.

Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

View Article
August 2017

A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin.

J Invest Dermatol 2017 01 14;137(1):62-70. Epub 2016 Sep 14.

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

View Article
January 2017

Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis.

Am J Hum Genet 2014 Jan;94(1):47-61

Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada 18016, Spain.

View Article
January 2014

Ultrasound assessment of subcutaneous compressibility: a potential adjunctive diagnostic tool in eosinophilic fasciitis.

J Clin Rheumatol 2013 Oct;19(7):382-5

From the *Division of Rheumatology and †Department of Dermatology, Boston University School of Medicine, Boston, MA; and ‡National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD.

View Article
October 2013

The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.

Ann Rheum Dis 2013 Jul 17;72(7):1188-93. Epub 2012 Aug 17.

Section of Rheumatology, Boston University School of Medicine, Boston, MA 02118, USA.

View Article
July 2013

Care of patients with scleroderma in the intensive care setting.

J Intensive Care Med 2010 Sep 11;25(5):247-58. Epub 2010 Jun 11.

Department of Medicine, Pulmonary Center, Boston University School of Medicine, Boston, MA, USA.

View Article
September 2010

Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?

Rheumatology (Oxford) 2010 Feb 23;49(2):201-2. Epub 2009 Dec 23.

View Article
February 2010

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis.

Arthritis Rheum 2009 Feb;60(2):578-83

Boston University School of Medicine, Boston, Massachusetts 02118, USA.

View Article
February 2009

Durometry for the assessment of skin disease in systemic sclerosis.

Arthritis Rheum 2006 Aug;55(4):603-9

Boston University School of Medicine, Boston, Massachusetts 02118, USA.

View Article
August 2006

Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosis.

Amyloid 2002 Dec;9(4):242-6

Thorndike Memorial Laboratory, Division of Medicine, Boston City Hospital, Arthritis Center, Boston University School of Medicine, Boston, Massachusetts, USA.

View Article
December 2002

Cytokine directed therapy in scleroderma: rationale, current status, and the future.

Curr Opin Rheumatol 2002 Nov;14(6):717-22

Rheumatology Section, Department of Medicine, Boston University School of Medicine, Massachusetts, USA.

View Article
November 2002

The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression.

J Bone Miner Res 2002 Aug;17(8):1512-26

Department of Medicine, Boston Medical Center, Massachusetts, USA.

View Article
August 2002